PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 192.00
+11.00 (6.08%)
At close: Mar 27, 2026
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 7.09 billion as of March 27, 2026. Its market cap has decreased by -29.05% in one year.
Market Cap
7.09B
Enterprise Value
4.27B
Revenue
684.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
192.00
Market Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 7.09B, a decrease of -60.25%. That is a compound annual growth rate of -41.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 7.09B | 23.14% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoTherapy Science | 8.29B |
| MEDINET | 8.00B |
| ADR120S | 7.88B |
| CellSource | 7.60B |
| Chiome Bioscience | 7.22B |
| Carna Biosciences | 7.14B |
| Noile-Immune Biotech | 6.41B |
| TMS Co., Ltd. | 6.28B |